Text Size

Cancer Related Fatigue in Patients Receiving Chemotherapy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2006 by Medical Center Alkmaar.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Medical Center Alkmaar
ClinicalTrials.gov Identifier:
NCT00261534
First received: December 1, 2005
Last updated: September 13, 2006
Last verified: September 2006
History of Changes
  Purpose

The purpose of this study is to examine the degree of fatigue in patients receiving chemotherapy. Special interest goes out to the course of fatigue throughout five treatments and the actions taken by patients to reduce this fatigue.The correlation between fatigue and haemoglobin will also be subject of study.


Condition
Cancer
Fatigue

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Outcomes Research on the Course of Cancer Related Fatigue Throughout Five Chemotherapy Treatments

Resource links provided by NLM:

MedlinePlus related topics: Cancer Fatigue
U.S. FDA Resources

Further study details as provided by Medical Center Alkmaar:

Estimated Enrollment: 90
Study Start Date: January 2006
Estimated Study Completion Date: July 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of cancer requiring chemotherapy treatment

Exclusion Criteria:

  • Pregnancy
  • Psychological illness
  • Life expectancy less than three months
  • Lack of basic proficiency in Dutch
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00261534

Locations
Netherlands
Medical Centre Alkmaar
Alkmaar, Noord-Holland, Netherlands, 1815JD
Sponsors and Collaborators
Medical Center Alkmaar
Investigators
Study Director: D. Hilarius, MSc Medical Centre Alkmaar, Hospital Pharmacy
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00261534     History of Changes
Other Study ID Numbers: M05-057
Study First Received: December 1, 2005
Last Updated: September 13, 2006
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by Medical Center Alkmaar:
Chemotherapy

Additional relevant MeSH terms:
Fatigue
Signs and Symptoms

ClinicalTrials.gov processed this record on May 19, 2013